Cangzhou Enke Pharma-tech Co. Ltd
Cangzhou Enke Pharma-tech Co. Ltd., commonly referred to as Enke Pharma, is a leading player in the pharmaceutical and biotechnology industry, headquartered in Cangzhou, China. Established in 2003, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. Enke Pharma's core offerings include a diverse range of APIs and custom synthesis services, distinguished by their commitment to innovation and stringent quality control. The company has achieved notable milestones, including certifications from various international regulatory bodies, which solidify its reputation as a trusted supplier in the pharmaceutical sector. With a strong market position, Enke Pharma continues to expand its operational footprint, focusing on research and development to meet the evolving needs of the global healthcare landscape.
DitchCarbon Score
How does Cangzhou Enke Pharma-tech Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cangzhou Enke Pharma-tech Co. Ltd's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cangzhou Enke Pharma-tech Co. Ltd's reported carbon emissions
Cangzhou Enke Pharma-tech Co. Ltd, headquartered in CN, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, which limits the ability to assess their environmental impact or sustainability efforts. In the context of the pharmaceutical industry, where climate commitments are increasingly vital, Cangzhou Enke Pharma-tech's lack of disclosed emissions data and reduction strategies may suggest an area for potential improvement in transparency and environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cangzhou Enke Pharma-tech Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
